These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16269592)

  • 1. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.
    Cohen-Solal A; Rouzet F; Berdeaux A; Le Guludec D; Abergel E; Syrota A; Merlet P
    J Nucl Med; 2005 Nov; 46(11):1796-803. PubMed ID: 16269592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
    Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
    Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
    Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
    J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure.
    Cohen Solal A; Jondeau G; Beauvais F; Berdeaux A
    Eur J Heart Fail; 2004 Jun; 6(4):463-6. PubMed ID: 15182772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.
    Choi JY; Lee KH; Hong KP; Kim BT; Seo JD; Lee WR; Lee SH
    J Nucl Cardiol; 2001; 8(1):4-9. PubMed ID: 11182704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure].
    Castro P; Pérez O; Greig D; Díaz-Araya G; Moraga F; Chiong M; Troncoso R; Padilla I; Vukasovic JL; Corbalán R; Lavandero S
    Rev Esp Cardiol; 2004 Nov; 57(11):1053-8. PubMed ID: 15544754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.